Transplant Outcomes for Children with T-Cell Acute Lymphoblastic Leukemia in Second Remission: A Report of the CIBMTR(®)

Survival for children with relapsed T-ALL is poor when treated with chemotherapy alone and outcomes after allogeneic hematopoietic cell transplantation (HCT) is not well described. Two hundred and twenty-nine children with T-ALL in second complete remission (CR2) received a HCT following myeloablati...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biol Blood Marrow Transplant
Glavni autori: Burke, Michael J., Verneris, Michael R., Le Rademacher, Jennifer, He, Wensheng, Abdel-Azim, Hisham, Abraham, Allistair A., Auletta, Jeffery J., Ayas, Mouhab, Brown, Valerie I., Cairo, Mitchell S., Chan, Ka Wah, Diaz Perez, Miguel A., Dvorak, Christopher C., Egeler, R. Maarten, Eldjerou, Lamis, Frangoul, Haydar, Guilcher, Gregory M. T., Hayashi, Robert J., Ibrahim, Ahmed, Kasow, Kimberly A., Leung, Wing H., Olsson, Richard F., Pulsipher, Michael A., Shah, Niketa, Shah, Nirali N., Thiel, Elizabeth, Talano, Julie-An, Kitko, Carrie L.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4654112/
https://ncbi.nlm.nih.gov/pubmed/26327632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.08.023
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items